Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Genetic epidemiology of breast and ovarian cancers.

Newman B, Millikan RC, King MC.

Epidemiol Rev. 1997;19(1):69-79. Review. No abstract available.

PMID:
9360904
2.

Hereditary breast and ovarian cancers.

Herman LM; Clinical and Scientific Affairs Council of the AAPA.

JAAPA. 2008 May;21(5):18, 21. Review. No abstract available.

PMID:
18556884
3.

Hereditary breast and ovarian cancers.

Carroll JC, Cremin C, Allanson J, Blaine SM, Dorman H, Gibbons CA, Grimshaw J, Honeywell C, Meschino WS, Permaul J, Wilson BJ.

Can Fam Physician. 2008 Dec;54(12):1691-2. Review. No abstract available.

4.

[Genetic risk of breast and ovarian cancer].

Eisinger F.

Chirurgie. 1998 Sep;123(4):399-403; discussion 403-4. Review. French. No abstract available.

PMID:
9828516
5.

Mutational spectrum of p53 mutations in primary breast and ovarian tumors.

Feki A, Irminger-Finger I.

Crit Rev Oncol Hematol. 2004 Nov;52(2):103-16. Review.

PMID:
15501075
6.
7.

Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2.

Liede A, Narod SA.

Hum Mutat. 2002 Dec;20(6):413-24. Review.

PMID:
12442265
8.

Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives.

Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Nomura AM, Kolonel LN.

Am J Epidemiol. 2004 Apr 15;159(8):750-8.

PMID:
15051584
9.

The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives.

Skasko E, Paszko Z, Niwińska A, Kwiatkowska E, Kruczek A, Pieńkowski T.

Eur J Gynaecol Oncol. 2004;25(4):470-4.

PMID:
15285306
10.

Case study: Mary is a healthy 33-year-old woman concerned about her risk of breast cancer.

Weber BL, Watson P, Stefanek ME, Wells NL, Helzlsouer KJ.

Cancer Pract. 1994 Jul-Aug;2(4):252-5. No abstract available.

PMID:
7858651
11.

Genetic/familial high-risk assessment: breast and ovarian.

Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, Offit K, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2006 Feb;4(2):156-76. No abstract available.

PMID:
16451772
12.

High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families.

Gronwald J, Elsakov P, Górski B, Lubiński J.

Breast Cancer Res Treat. 2005 Nov;94(2):111-3.

PMID:
16261409
13.

Genetic epidemiology with a capital "E".

Thomas DC.

Genet Epidemiol. 2000 Dec;19(4):289-300.

PMID:
11108640
14.

Evaluation of familial clustering of breast and prostate cancer in the Minnesota Breast Cancer Family Study.

Grabrick DM, Cerhan JR, Vierkant RA, Therneau TM, Cheville JC, Tindall DJ, Sellers TA.

Cancer Detect Prev. 2003;27(1):30-6.

PMID:
12600415
15.

The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series.

Møller P, Borg A, Heimdal K, Apold J, Vallon-Christersson J, Hovig E, Maehle L; Norwegian Inherited Breast Cancer Group; Norwegian Inherited Ovarian Cancer Group.

Eur J Cancer. 2001 May;37(8):1027-32.

PMID:
11334729
16.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
17.

One risk fits all?

De Bock GH, Mourits MJ, Oosterwijk JC.

J Clin Oncol. 2007 Aug 1;25(22):3383-4; author reply 3384. No abstract available.

PMID:
17664491
18.

New method predicts risk of breast-ovarian cancer gene mutations.

[No authors listed]

Int J Fertil Womens Med. 1997 Nov-Dec;42(6):405. No abstract available.

PMID:
9459083
19.

Breast & ovarian cancer. Issues in risk assessment.

Caro SW.

Adv Nurse Pract. 1999 Aug;7(8):26-32; quiz 33-4. Review. No abstract available.

PMID:
10745719
20.

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA.

J Natl Cancer Inst. 2006 Dec 6;98(23):1694-706.

PMID:
17148771

Supplemental Content

Support Center